The blood S-glutathionylated GAPDH levels of patients with AD had to reach least 752.7 ± 301.7 ng/dL before a diagnosis could be made through comprehensive examinations involving MMSE, CT, and/or MRI at the Outpatient Neurology Clinic (Table 1). The gene discussed is GAPDH; the disease is Alzheimer disease.